Suppr超能文献

GM1神经节苷脂贮积症和B型黏多糖贮积症Ⅳ型的分子基础。溶酶体β-半乳糖苷酶和非溶酶体β-半乳糖苷酶样蛋白的结构-功能研究。

Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.

作者信息

Callahan J W

机构信息

Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, ON, Canada.

出版信息

Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103. doi: 10.1016/s0925-4439(99)00075-7.

Abstract

GM1 gangliosidosis and Morquio B disease are distinct disorders both clinically and biochemically yet they arise from the same beta-galactosidase enzyme deficiency. On the other hand, galactosialidosis and sialidosis share common clinical and biochemical features, yet they arise from two separate enzyme deficiencies, namely, protective protein/cathepsin A and neuraminidase, respectively. However distinct, in practice these disorders overlap both clinically and biochemically so that easy discrimination between them is sometimes difficult. The principle reason for this may be found in the fact that these three enzymes form a unique complex in lysosomes that is required for their stability and posttranslational processing. In this review, I focus mainly on the primary and secondary beta-galactosidase deficiency states and offer some hypotheses to account for differences between GM1 gangliosidosis and Morquio B disease.

摘要

GM1神经节苷脂贮积症和莫尔基奥B病在临床和生化方面都是不同的疾病,但它们都源于相同的β-半乳糖苷酶缺乏。另一方面,半乳糖唾液酸贮积症和唾液酸贮积症具有共同的临床和生化特征,但它们分别源于两种不同的酶缺乏,即保护蛋白/组织蛋白酶A和神经氨酸酶。然而,尽管这些疾病各不相同,但在实际中它们在临床和生化方面都存在重叠,因此有时很难将它们轻易区分开来。造成这种情况的主要原因可能是这三种酶在溶酶体中形成了一种独特的复合物,而这种复合物是它们稳定性和翻译后加工所必需的。在这篇综述中,我主要关注原发性和继发性β-半乳糖苷酶缺乏状态,并提出一些假说来解释GM1神经节苷脂贮积症和莫尔基奥B病之间的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验